PLOD1 and hypogonadotropic hypogonadism: Also, only in few countries the combination of r-FSH + r-LH in a 2:1 ratio (Pergoveris, Merck, Germany) for the treatment of patients with hypogonadotropic hypogonadism [14], is also licensed for COS.